[AKRO] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
06-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 19.79%
YoY- -72.35%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -23,059 -35,542 -27,403 -26,029 -32,424 -24,330 -28,933 -14.00%
Tax -2,574 -549 297 -22 -11 -51 -50 1273.96%
NP -20,485 -34,993 -27,403 -26,007 -32,424 -24,330 -28,933 -20.51%
Tax Rate - - - - - - - -
Total Cost 20,485 34,993 27,403 26,007 32,424 24,330 28,933 -20.51%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.44 -0.91 -0.77 -0.74 -0.93 -0.70 -0.83 -34.42%
EPS Diluted -0.44 -0.91 -0.77 -0.74 -0.93 -0.70 -0.83 -34.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.